Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversibility of Dual Antiplatelet Therapy by Platelets.Phase II Study

NCT01248351 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT01248351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01248351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversibility of Dual Antiplatelet Therapy by Platelets.Phase II Study
Lead sponsor
Medical University of Graz
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2010
Completion date
March 31, 2011
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding